A Newly Established Cuproptosis-Associated Long Non-Coding RNA Signature for Predicting Prognosis and Indicating Immune Microenvironment Features in Soft Tissue Sarcoma

Figure 4

The prognostic performance of the 5 cuproptosis-associated lncRNAs of the signature in the training group, testing group, and all patients. (a–c) The expression heatmap of 5 cuproptosis-associated lncRNAs in the training group, testing group, and all patients. (d–f) The distribution of the risk scores in the training group, testing group, and all patients. (g–i) In the training group, testing group, and all patients, the scatter plots show whether the samples were alive or not. (j–l) The K-M curves depicting the OS in high-risk and low-risk groups in the training group, testing group, and all patients. (m–o) The prognostic accuracy of the risk scores in the training group, testing group, and all patients was verified by the ROC curve. ROC, receiver operating characteristic.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)

(l)

(m)

(n)

(o)